Non-invasive therapeutic brain stimulation for treatment of resistant focal epilepsy in a teenager.
Clin Neurophysiol Pract 2020;
5:142-146. [PMID:
32875174 PMCID:
PMC7451717 DOI:
10.1016/j.cnp.2020.07.003]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 05/11/2020] [Accepted: 07/12/2020] [Indexed: 12/03/2022] Open
Abstract
rTMS and tDCS could be more often used for treatment-resistant focal epilepsy and tinnitus.
tDCS can be used as maintenance treatment after initial successful rTMS treatment.
rTMS and tDCS are safe in adolescents when current safety instructions are followed.
Aims
A 13-year-old boy with symptomatic focal epilepsy due to a right parietal dysembryoplastic neuroepithelial tumor (DNET) presented pre- and post-operatively fluctuating tinnitus and sensory symptoms which became persistent after incomplete tumor resection. He received low-frequency rTMS treatment and cathodal tDCS treatment.
Methods
Case report with clinical details and pictures from rTMS and tDCS stimulation targets.
Results
The patient became symptom free with an initial low-frequency rTMS treatment series targeted to the EEG-verified epileptic zone followed by maintenance therapy at the same region with cathodal tDCS at home.
Conclusions
Both rTMS and tDCS could be more often used in adolescents when drug treatment and surgery do not cease focal epilepsy, here with fluctuating tinnitus.
Collapse